Research spotlight: Innovative immunotherapy for malignant brain tumors
2022 Clinical Science Research Award winner Duane Mitchell, M.D., Ph.D., translates work from lab to clinic
Nov. 17, 2022 — As a physician-scientist, neuro-oncologist Duane Mitchell, M.D., Ph.D., aims to discover better treatments for patients to improve their quality of life.
Mitchell, the Phyllis Kottler Friedman Professor in the Lillian S. Wells Department of Neurosurgery and co-director of the Preston A. Wells Jr. Center for Brain Tumor Therapy at UF Health, is a leading expert in the development of innovative immunotherapy treatments for adults and children with malignant brain tumors. Mitchell, also the director of the UF Clinical and Translational Science Institute, has pioneered many novel brain tumor immunotherapies that have been translated into first-in-human clinical trials and multicenter phase 2 studies.
He is the recipient of the 2022 College of Medicine Clinical Science Research Award, given for research that has a close connection to clinical medicine and/or has an impact on the delivery of patient care.
Learn more about Mitchell and his lab’s research in the video below: